It is a research & development private limited company based in Bangalore, Karnataka, India, established in 2011.
2011 | Bangalore, Karnataka, India | Struck OffStem Cell And Tissue Engineering Research Private Limited, a struck off private limited company, was established on 22 November 2011 in Bangalore, Karnataka, India. Engaging in research & development within the professional, scientific and technical sector, it holds CIN: U73100KA2011PTC061274. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹4.10 M and a paid-up capital of ₹4.07 M.
It upholds a compliant status. Its leadership includes Shama Bhat (Managing Director), Susheela Shama Bhat (Director). Past directors included Manoj Vinoy Mojamdar. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at 11- A, 4Th Cross, Veerasandra Industrial Area , Electronic City, Bangalore, Karnataka, 560100.
U73100KA2011PTC061274
061274
22 November 2011
₹4.10 M
₹4.07 M
Roc Bangalore
Unlisted
Struck Off
Explore comprehensive insights into Stem Cell And Tissue Engineering Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shama Bhat | Managing Director | 22 Nov 2011 | Current |
| Susheela Shama Bhat | Director | 22 Nov 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Jul 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Stem Cell And Tissue Engineering Research Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 60.72% increase in profit. The company's net worth dipped by a decrease of 0.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Stem Cell And Tissue Engineering Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Stem Cell And Tissue Engineering Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Stem Cell And Tissue Engineering Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stem Cell And Tissue Engineering Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Stem Cell And Tissue Engineering Research Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was completed.
Progress on Stem Cell And Tissue Engineering Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Bangalore. was documented.
Progress on Shama Bhat was appointed as a Managing Director was appointed as a Managing Director on 22 Nov 2011 & has been associated with this company since 14 years 13 days . was documented.
Progress on Susheela Shama Bhat was appointed as a Director was appointed as a Director on 22 Nov 2011 & has been associated with this company since 14 years 13 days . was documented.
The activity Stem Cell And Tissue Engineering Research Private Limited was registered on 22 Nov 2011 with Roc Bangalore & aged 14 years 13 days as per MCA records. was completed.
The CIN of Stem Cell And Tissue Engineering Research Private Limited is U73100KA2011PTC061274.
Stem Cell And Tissue Engineering Research Private Limited is headquartered at 11- A, 4Th Cross, Veerasandra Industrial Area , Electronic City, Bangalore, Karnataka, 560100.
Stem Cell And Tissue Engineering Research Private Limited was incorporated on 22 November 2011.
The current directors of Stem Cell And Tissue Engineering Research Private Limited are
The primary industry of Stem Cell And Tissue Engineering Research Private Limited is Professional, Scientific And Technical.
Stem Cell And Tissue Engineering Research Private Limited is unlisted.
The authorized capital of Stem Cell And Tissue Engineering Research Private Limited is ₹4.10 M, and the paid-up capital is ₹4.07 M.
The compliance status of Stem Cell And Tissue Engineering Research Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX